RE:RE:RE:RevenuesThat could provide clarity and confidence that the plant would go ahead.
They said it would be a go ahead as they would pursue Y-BG alone as an immune booster. The selection of a partner for PGX CoQ10 was to be announced in H2. Both require a commercial pilot plant. We still don't know the reason for the delay for completion, an explanation was lacking in the NR. The uncertainty adds to sellig pressure.